Integrated bulk and single-cell transcriptomics reveal PANoptosis-linked immune programs and potential therapeutic targets in retinoblastoma

Background Retinoblastoma (RB) is the most common intraocular malignancy in children, but the role of PANoptosis, an integrated programmed cell death pathway involving apoptosis, pyroptosis, and necroptosis, remains unclear. Methods Bulk transcriptomic datasets from the GEO database were analyzed to identify PANoptosis-related differentially expressed genes (DEGs) in RB. Machine-learning algorithms were applied to develop a diagnostic signature. Functional enrichment, immune infiltration, drug–gene interaction, and ceRNA analyses were performed. Single-cell RNA sequencing was used to characterize the cellular distribution and biological functions of PANoptosis-related genes. Paired RB and adjacent retinal tissues from five patients were collected for RT-qPCR and western blot validation. Results Twenty-two PANoptosis-related DEGs were identified, and an exploratory five-gene signature consisting of BAX, CRADD, CD14, LY96, and TICAM1 showed promising apparent diagnostic discrimination in RB. External expression and ROC analyses provided additional support, although the small control cohorts limit performance inference. Single-cell analysis suggested different cellular distributions: BAX was relatively broadly detected in cone precursor-like tumor populations, whereas CD14 and LY96 were enriched in the microglia/macrophage compartment. Preliminary validation in five paired clinical specimens showed increased BAX, CD14, LY96, and TICAM1 mRNA expression and reduced CRADD expression; BAX protein abundance was also increased. Conclusions The five-gene PANoptosis-related signature represents an exploratory molecular finding in RB. Its clinical diagnostic value and mechanistic or therapeutic relevance require validation in larger independent cohorts and functional experiments.

Authors

Institutions

Publication Details

Journal
Frontiers in Oncology
Published
2026-11-16
DOI
https://doi.org/10.3389/fonc.2026.2023937
Primary Topic
Ocular Oncology and Treatments
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Integrated bulk and single-cell transcriptomics reveal PANoptosis-linked immune programs and potential therapeutic targets in retinoblastoma

Qiurong Long, 赵粟, Hao Jiang, Hao Gu et al.
2 links
Frontiers in Oncology
Ocular Oncology and Treatments
article

Integrated bulk and single-cell transcriptomics reveal PANoptosis-linked immune programs and potential therapeutic targets in retinoblastoma

Qiurong Long, 赵粟, Hao Jiang, Hao Gu, Xiu Long, Jun Jiang, Yucheng Yao, Xueer Zheng, Mei Yang, Bo Jiang
article en

Abstract

Background Retinoblastoma (RB) is the most common intraocular malignancy in children, but the role of PANoptosis, an integrated programmed cell death pathway involving apoptosis, pyroptosis, and necroptosis, remains unclear. Methods Bulk transcriptomic datasets from the GEO database were analyzed to identify PANoptosis-related differentially expressed genes (DEGs) in RB. Machine-learning algorithms were applied to develop a diagnostic signature. Functional enrichment, immune infiltration, drug–gene interaction, and ceRNA analyses were performed. Single-cell RNA sequencing was used to characterize the cellular distribution and biological functions of PANoptosis-related genes. Paired RB and adjacent retinal tissues from five patients were collected for RT-qPCR and western blot validation. Results Twenty-two PANoptosis-related DEGs were identified, and an exploratory five-gene signature consisting of BAX, CRADD, CD14, LY96, and TICAM1 showed promising apparent diagnostic discrimination in RB. External expression and ROC analyses provided additional support, although the small control cohorts limit performance inference. Single-cell analysis suggested different cellular distributions: BAX was relatively broadly detected in cone precursor-like tumor populations, whereas CD14 and LY96 were enriched in the microglia/macrophage compartment. Preliminary validation in five paired clinical specimens showed increased BAX, CD14, LY96, and TICAM1 mRNA expression and reduced CRADD expression; BAX protein abundance was also increased. Conclusions The five-gene PANoptosis-related signature represents an exploratory molecular finding in RB. Its clinical diagnostic value and mechanistic or therapeutic relevance require validation in larger independent cohorts and functional experiments.

Frontiers in OncologyVol. 16
Guiyang Medical University (CN), Affiliated Hospital of Guizhou Medical University (CN)
Good health and well-being
Ocular Oncology and Treatments
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon